Latest Health & Nutrition News and Videos
OpenAI, Google, Anthropic and Amazon put health
A new blood-based signature predicts type 2 diab
New study shows APOE genetics may explain up to
Milan-based healthtech startup closes $2.
Up to $287 million Series D1 backs CORXEL’s bi
Alterity Therapeutics Ltd.
Life Time Group Holdings, Inc., the U.S.
BioAge Labs, Inc.
Hundred Health founder on why building the ‘de
Pooled MRI and memory data from thousands of adu
L-Nutra to establish manufacturing center in Abu
Beauty is moving beyond ‘antiaging’ toward p
Amycretin enters phase III trials, promising fas
Insilico Medicine and Hygtia Therapeutics have en
Thorne, a science‑driven health and wellness co
Biomodal Ltd.
L‑Nutra Inc.
The global AI in clinical trials market is expect
dōTERRA International, a global leader in essent
New kit aims to quantify internal exposure in 7–10 days, offering a noninvasive way to track microplastic particle counts over time. Microplastics have been detected in air, water and food, and increasingly in human biological samples, raising questions about what chronic exposure might mean for long-term health. Yet for most people, the conversation has remained abstract – a concern in headlines rather than a measurable personal variable. California-based longevity and environmental health company Lumati says it is aiming to change that with Lumati Detect, which it describes as the first at-home saliva test designed to measure microplastic exposure inside the human body. The mail-in kit, which sold out during its launch at A4M Longevity Fest, allows users to collect a saliva sample at home, send it to a certified US laboratory for analysis. Customers then receive a secure digital report within seven to 10 days, with results including total particle count, concentration and size ranges. Longevity.Technology: Microplastics have become big news, making the leap from obscure toxicology to mainstream dinner-party dread with remarkable speed. This makes Lumati’s at-home saliva test feel like a product arriving bang on cue; when the public can sense a problem but can’t quantify it, measurement…
Oxford researchers create fluorescent proteins t
AI-discovered drug displays anti-inflammatory ac
Stanford-led model turns overnight sleep data in
The longevity biotech expands BGE-102 into diabe
Investor backing spotlights a quieter, human-cen
The global next-generation drug conjugates market
Serpin Pharma Inc.
A novel imaging tool paired with a diabetes drug
Global pioneers in NAD+ solutions set for future
Scribe’s CRISPR-based cholesterol reduction th
A new market research report forecasts that the g
MEG scans show how disrupted sleep alters brain
New fast-track voucher program hits roadblocks,
Genflow Biosciences Plc, a UK-based biotechnology
From bespoke stem cells to automated biology, tw
New research shows the gut doesn’t just digest
Researchers seek to enable low-cost early diagno
$1.
Early results show weight loss, stronger mobilit
Amway Korea’s myWellness LAB combines AI and p
Life Time, a major sports event and fitness compa
The global medical spa market is projected to exp
The global medical spa market is projected to exp
The Houstonian Hotel, Club & Spa has appointed Fo
Immunis, a clinical-stage biotechnology company d
The global RNA therapy market is expected to grow
Commercial astronauts showed rapid DNA methylati
Biotech raises oversubscribed Series B to advanc
A new Japanese model presents a more accurate wa
New regenerative platform claims to rewind cellu